Xcout Intel
AcuraStem Inc
AcuraStem Inc. is a biotechnology company founded in 2016 and headquartered in Pasadena, California, focused on developing potential therapies for neurodegenerative diseases like ALS.
Subscribe to see AcuraStem Inc’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
AcuraStem Inc at a glance
AcuraStem Inc is a biotech company headquartered in United States. It has raised at least $58.5M across the 4 funding rounds on record. Its most recent funding round raised $5M in June 2026. Xcout tracks 11 named people at AcuraStem Inc, including Marcel van der Brug (Chief Scientific Officer).
AcuraStem Inc leadership
- Marcel van der BrugChief Scientific Officer
- Sam AlworthCo-founder and CEO
- Justin IchidaCo-founder
- Paul AugustCo-founder
- Qing LiuCo-founder
- Wen-Hsuan ChangAssociate Vice President, Discovery and Early Development
5 more named people on record for AcuraStem Inc, with roles, board committees and tenure — see the full roster →
AcuraStem Inc funding rounds
At least $58.5M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $5M | — | |
| SEC Form D filing | $3.1M | — | |
| — | $50M | 2 named | |
| SEC Form D filing | $380,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
AcuraStem Inc competitors
A few of AcuraStem Inc's closest competitors — see the full list of competitors and alternatives →
Aspen Neuroscience, Inc. is a clinical-stage private biotechnology company headquartered in San Diego, California. The company focuses on developing personalized autologous cell therapies for neurodegenerative diseases.
Asceneuron is a biotechnology research company founded in 2012 and headquartered in Eysins, Switzerland, focusing on the discovery and development of therapeutics for neurodegenerative disorders.
Neurona Therapeutics Inc. is a biotherapeutics company that focuses on developing cell-based therapies to address neurological disorders.
Libra Therapeutics is a biopharmaceutical company headquartered in Del Mar, California, focused on developing novel disease-modifying therapeutics. The company aims to restore cellular balance and improve lysosomal function to halt neurodegeneration in conditions such as amyotrophic lateral sclerosis.
ProJenX, Inc. is a clinical-stage biotechnology company founded in 2021 and headquartered in New York City. The firm focuses on neuroscience, developing novel, brain-penetrant therapies targeting biologically defined motor neuron diseases such as ALS. It advances research programs aimed at addressing severe neurodegenerative conditions.
Axonis Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, focused on discovering and developing novel treatments for neurological conditions and spinal cord injuries. Founded in 2019, the company advances therapeutic candidates through its proprietary research platform.
Get AcuraStem Inc's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on AcuraStem Inc in Xcout Intel
- 11 named people with titles, LinkedIn and board committees
- 4 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access